Your session is about to expire
← Back to Search
Resistance Exercise for Non-Small Cell Lung Cancer
Study Summary
This trial is investigating the feasibility and preliminary efficacy of a home-based, cluster-set resistance exercise program in individuals with NSCLC. The program is designed to target symptoms of dyspnea and fatigue, which can contribute to physical decline, reductions in quality of life, and a higher risk of comorbidities and mortality.
- Non-Small Cell Lung Cancer
- Resistance Training
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants have been inducted into this trial?
"Affirmative, the information on clinicaltrials.gov confirms that this research initiative is currently in progress. The trial was initially posted on January 1st 2022 and has recently been updated as of April 5th 2022. A total of 15 individuals are expected to be enrolled from just a single medical facility."
Are there any available openings in this investigation for participants?
"Affirmative. According to the information on clinicaltrials.gov, this trial is still in need of volunteers and was first posted on January 1st 2022 with its most recent edit occurring April 5th 2022. 15 participants are required at one medical site for successful completion of the research project."
What aims are researchers striving to achieve with this investigation?
"The overall objective of this research, which is expected to last for an average duration of one year, is patient retention. Additionally, as secondary outcomes the study evaluates Appendicular Lean Mass (sum of arm and leg fat free mass), Physical Function 6MWT (6-minute Walk Test distance in meters) and Bone Mineral Density total z-score Dual X-ray Absorptiometry)."
Share this study with friends
Copy Link
Messenger